| Literature DB >> 35141645 |
Anant Naik1, Christina M Moawad1, Samantha L Houser1, T Kesh Kesavadas2, Paul M Arnold1,2,3.
Abstract
BACKGROUND: We seek to characterize the features of iatrogenic spinal ischemia, determine which spinal levels are affected, and evaluate the efficacy of management strategies.Entities:
Year: 2021 PMID: 35141645 PMCID: PMC8819873 DOI: 10.1016/j.xnsj.2021.100080
Source DB: PubMed Journal: N Am Spine Soc J ISSN: 2666-5484
Fig. 1PRISMA Diagram elucidating the process of record identification.
Descriptive Statistics of Patient Population.
| Continuous Patient Features | μ (σ) | Range |
|---|---|---|
| Age (in years) | 59.62 (18.66) | 0.75 – 88 |
| Categorical Patient Features | N | % of total patients |
| Male | 59 | 66.29% |
| Females | 24 | 26.97% |
| Unknown | 6 | 6.74% |
| Endovascular Surgical Complication | 29 | 32.58% |
| Aortic Surgical Complication | 32 | 35.96% |
| Non-aortic Surgical Complications | 21 | 23.60% |
| Non-surgical Procedure | 20 | 22.47% |
| Motor impairment | 87 | 97.75% |
| Sensory impairment | 64 | 71.91% |
| Autonomic Impairment | 42 | 47.19% |
| ASIA A | 38 | 42.70% |
| ASIA B | 21 | 23.60% |
| ASIA C | 22 | 24.72% |
| ASIA D | 8 | 8.99% |
| ASIA E | 0 | 0.00% |
| Patients with infarction of known spinal level | 63 | 70.79% |
| anti-coagulation | 12 | 13.48% |
| anti-platelets | 12 | 13.48% |
| BP management | 36 | 40.45% |
| Mannitol | 4 | 4.49% |
| Naloxone | 2 | 2.25% |
| Steroids | 25 | 28.09% |
| CSF drainage | 29 | 32.58% |
| Therapeutic surgery | 14 | 15.73% |
| Endovascular Revascularization | 5 | 5.62% |
| Rehab | 44 | 49.44% |
| Hyperbaric Oxygen | 8 | 8.99% |
| Hypothermia | 1 | 1.12% |
| Edavarone | 2 | 2.25% |
Fig. 2Forest Plots of Primary Comparisons. A demonstrates the odds ratio of inciting factors for spinal cord infarction to result in improvement. B demonstrates the odds ratio of treatment strategies for spinal cord infarction to result in improvement. Asterisk (*) denotes significance (p < 0.05). Hash (#) denotes trend towards significance (p < 0.10).
Fig. 3Associations of Patient Features with Location of Ischemia. A shows the frequency distribution normalized to number of individuals in each cohort for different patient features, defined to be (F/N). A scale bar representing the value of 0.1 F/N is shown. B shows the normalized frequency distribution for cervical, upper thoracic (T1-T6), lower thoracic (T6-T12) to lumbar regions for inciting factors of spinal infarction. C shows the normalized frequency distribution for C, UT, LT, L regions for severity and total outcomes.
Outcomes for Emergent and Less Frequent Therapeutics and Surgeries.
| Treatment | Patient # | ASIA Score | Death | Worsened | No Change | Some Improvement | Mostly Improved | Full Improvement |
|---|---|---|---|---|---|---|---|---|
| 1 | B | |||||||
| 2 | A | |||||||
| 3 | A | |||||||
| 4 | C | |||||||
| 5 | A | |||||||
| 6 | A | |||||||
| 7 | A | |||||||
| 8 | A | |||||||
| 1 | A | |||||||
| 2 | C | |||||||
| 3 | C | |||||||
| 4 | B | |||||||
| 1 | B | |||||||
| 2 | C | |||||||
| 1 | A | |||||||
| 2 | B | |||||||
| 3 | A | |||||||
| 4 | C | |||||||
| 1 | C | |||||||
| 2 | C | |||||||
| Endovascular Revascularization Procedure | 1 | A | x | |||||
| 2 | A | x | ||||||
| 3 | A | x* | ||||||
| 4 | D | x | ||||||
| 5 | A | x | ||||||
| Open Revascularization | 1 | B | x | |||||
| 2 | D | x | ||||||
| 3 | A | x | ||||||
| 4 | A | x | ||||||
| 5 | A | x | ||||||
| 6 | A | x | ||||||
| Discectomy/ | ||||||||
| Laminectomy/ | ||||||||
| Laminoplasty | 1 | B | x | |||||
| 2 | B | x | ||||||
| 3 | A | x* | ||||||
| Removal of Pathology (tumor, AVM, hematoma) | 1 | B | x |
x* refers to the same patient with both procedures.